Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Bacampicillin-hydrochloride

Bacampicillin-hydrochloride

pharmaceutical raw materials
Bacampicillin-hydrochloride structure

Bacampicillin-hydrochloride 

structure
  • CAS No:

    37661-08-8

  • Formula:

    C21H27N3O7S.ClH

  • Chemical Name:

    Bacampicillin-hydrochloride

  • Synonyms:

    4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-,1-[(ethoxycarbonyl)oxy]ethyl ester,hydrochloride (1:1),(2S,5R,6R)-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-,1-[(ethoxycarbonyl)oxy]ethyl ester,monohydrochloride,[2S-[2α,5α,6β(S*)]]-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-,1-[(ethoxycarbonyl)oxy]ethyl ester,monohydrochloride,(2S,5R,6R)-;Bacampicillin-hydrochloride;Becampicillin hydrochloride;Penglobe;Bacampicine;Bacacil;Spectrobid;Ambacamp;Ambaxin

  • Categories:

    Active Pharmaceutical Ingredients  >  Antibiotics

Description

Bacampicillin hydrochloride is a penicillin antibiotic, is a prodrug of ampicillin with improved oral bioavailability.


Bacampicillin Hydrochloride is the hydrochloride salt of bacampicillin, a prodrug of ampicillin, a broad-spectrum, semisynthetic, beta-lactam aminopenicillin antibiotic with bactericidal activity. Bacampicillin is hydrolyzed in vivo by esterases to its active metabolite ampicillin. Ampicillin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis.

Bacampicillin-hydrochloride Basic Attributes

501.98

501.13400

253-580-4

DTXSID0045466

C65246

Characteristics

163

3.12690

171-176 °C (decomp)

695.4ºC at 760 mmHg

374.3ºC

Intravenous-rat LD50: 176 mg/kg; peritoneal-mouse LD50; 176 mg/kg

Combustible; burning produces fumes of toxic nitrogen oxides, sulfur oxides and hydrogen chloride

D20 +161.5°

199 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|220.8 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

Ventilated, low temperature and dry; stored separately from food materials in warehouse

Toxicity

highly toxic

Drug Information

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

bacampicillin

Bacampicillin-hydrochloride Use and Manufacturing

Uses

Bacampicillin is a penicillin class of antibiotic. Bacampicillin is a prodrug of ampicillin (A634300) with improved oral bioavailability.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:502.0
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:10
Exact Mass:501.1336491
Monoisotopic Mass:501.1336491
Topological Polar Surface Area:163
Heavy Atom Count:33
Complexity:756
Defined Atom Stereocenter Count:4
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Bacampicillin is ampicillin methyl amyl ester, which has no antibacterial activity in vitro. During in vivo absorption, it is hydrolyzed into ampicillin by nonspecific esterases in the intestinal wall to exert its antibacterial effect. Ampicillin sodium is a broad-spectrum semi-synthetic penicillin. It is effective against a variety of Gram-positive and Gram-negative bacteria and exerts its bactericidal effect by inhibiting bacterial cell wall synthesis.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • FRESENIUS KABI IPSUM S.R.L.

    European Union European Union
    Active
  • ASTRA LAKEMEDEL AB

    United States United States
    Inactive
  • Kyongbo Pharmaceutical Co., Ltd.

    European Union European Union
    Inactive

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.